Table 4.

Demographic patient data (age, BMI) and blood count of patients with dedifferentiated liposarcoma, healthy donors (Individual Cohort (IC)) and lipoma patients

Patients	Age (years)	BMI	Hb	Platelets	Leukocytes
		(kg/m${}^2$)	(g/dl)	($\times$ 10${}^8$/l)	($\times$ 10${}^8$/l)
G2 liposarcoma patients ($n=$ 3)	64.33 $\pm$ 4.41	24.91 $\pm$ 3.08	11.10 $\pm$ 1.75	272.00 $\pm$ 31.19	5.52 $\pm$ 0.97
G3 liposarcoma patients ($n=$ 3)	80.33 $\pm$ 4.41	28.05 $\pm$ 2.10	13.73 $\pm$ 1.94	244.00 $\pm$ 45.36	8.75 $\pm$ 3.26
G2 and G3 liposarcoma patients ($n=$ 6)	72.50 $\pm$ 4.65	26.48 $\pm$ 1.81	12.42 $\pm$ 1.31	258.00 $\pm$ 25.40	7.13 $\pm$ 1.68
Healthy controls (IC) ($n=$ 3)	45.33 $\pm$ 2.19	29.82 $\pm$ 3.11	14.53 $\pm$ 0.38	272.70 $\pm$ 39.46	6.06 $\pm$ 0.76
Lipoma patients ($n=$ 5)	54.80 $\pm$ 5.76	25.17 $\pm$ 2.15	14.72 $\pm$ 0.21	225.60 $\pm$ 19.98	5.87 $\pm$ 0.39
p-value of G2 liposarcoma patients vs.	0.0181	0.3249	0.1274	0.9901	0.6853
healthy Controls (IC)
p-value of G3 liposarcoma patients vs.	0.0021	0.6620	0.7066	0.6584	0.4673
healthy controls (IC)
p-value of G2 liposarcoma patients vs.	0.2957	0.9465	0.0323	0.2338	0.7039
lipoma patients
p-value of G3 liposarcoma patients vs.	0.0220	0.4100	0.5199	0.6802	0.2834
lipoma patients

Data are presented as mean value $\pm$ standard error of mean (SEM). Age, BMI, Hb-, leukocyte- and platelet-values were rounded to 2 decimal digits; while p-values were rounded to 4 decimal digits. p-values were determined using a Student’s t-test for independent samples. Hb $=$ Hemoglobin. BMI $=$ Body Mass Index. IC $=$ Independent Cohort.